A Science and Technology Blog
The Pune-based Serum Institute of India has already begun manufacturing the Oxford vaccine (ChAdOx1 nCoV-19) for novel coronavirus. The company intends to manufacture two-three million doses by end-August. The Pune-based…
Never before have candidate vaccines been developed from scratch, tested on animals and completed early stages of human clinical trials all under six months. This is an acid test for…
Phase-2 trial using a single dose of recombinant adenovirus vaccine (Ad5-nCoV) vector carries the genetic material that codes for spike glycoprotein of novel coronavirus was found to be safe, well-tolerated,…
A realistic (but very optimistic) timeline from the start of Phase-1 to the completion of Phase-3 could be about six to nine months (if all goes exactly according to plan),…
A day after serious concerns were raised, ICMR has reversed its stand. It says its decision to fast-track the trial process was only to cut the red-tape and not to…
On July 2, ICMR had sent a threatening letter sent to principal investigators at 12 sites to complete the Phase-1/phase-2 trail of India’s first indigenous COVID-19 vaccine by August 15.…
With the pandemic raging across many countries and the demand for a safe, efficacious vaccine being huge, availability of an indigenous vaccine will mean guaranteed availability for Indians, while a…
The results of the Phase-1 clinical trial of the Oxford vaccine (ChAdOx1 nCoV-19) to prevent infection by novel coronavirus are expected by the first week of July. Serum Institute of…
